Michael Bernell in Shenandoah, Texas

Home Texas Shenandoah

Michael Bernell has Anesthesiology as his primary medical specialty. Their primary office is: 9250 Pinecroft Dr in Shenandoah, Texas.

They're a part of the: U S Anesthesia Partners Of Texas, Pa medical group which has around 2,385 members. You can call their office at 713-620-4000 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Texas Medical Branch At Galveston and graduated in 2010 (around 14 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Michael Joseph Bernell Office Phone and Directions

Michael Bernell
U S Anesthesia Partners Of Texas, Pa
9250 Pinecroft Dr
Shenandoah, Texas 77380
713-620-4000

Patient Ratings
Please rate your experience with Michael Bernell below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 713-620-4000

Enter a starting address:

Healthcare Info for Michael Bernell

Medical School: University Of Texas Medical Branch At Galveston
Graduation Year: 2010
The Primary Medical Specialty for Michael Bernell is listed as: Anesthesiology
Approximate Years of Experience: 14
PAC (PECOS ID)#: 1052625803
NPI #: 1801116850
NPI Created On: 06/01/2010
NPI Last Updated Listed as: 08/18/2021
Primary Taxonomy Code: 207L00000X
License Number:
R1706
Listed Gender: Male

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 848341801

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: NEUROSCIENCE

Name of Drug #1: BRIDION

Open Associated Drug #1: 0006-5423-15